19 Basis Points Stand Between iShares MSCI World ETF’s Gold Rating and Market Leadership

Morningstar awards URTH its highest rating, but a 19-bp fee gap to cheaper rivals challenges investors. Heavy tech tilt, strong inflows, Fed meeting ahead.

A Morningstar gold medal typically signals that a fund has everything going for it. But for the iShares MSCI World ETF (URTH), that stamp of approval arrives at a moment when its cost advantage is under serious pressure. The analysis house awarded the fund its highest conviction rating on 27 April 2026, highlighting strong risk-adjusted returns, a five-star 10-year track record, and a tracking difference of just 0.02 percent. Yet the fee gap to cheaper rivals has never been wider.

URTH charges 0.24 percent in total expenses per year. Invesco slashed the fee on its competing MSCI World ETF to 0.05 percent on 1 April, while UBS and BNP Paribas have also trimmed their pricing. That creates a 19-basis-point chasm — a spread that compounds significantly over long holding periods. Morningstar may vouch for the fund’s quality, but cost-conscious investors now have a clear mathematical reason to look elsewhere.

The fund’s composition remains dominated by US technology names. NVIDIA is the top holding at 5.55 percent, followed by Apple at 4.56 percent and Microsoft at 3.29 percent. The top ten positions together account for roughly 27 percent of assets. The information technology weighting stands at 27.61 percent, a concentration that can amplify both gains and losses when interest rate expectations shift. NVIDIA has been on a tear: it reported quarterly revenue of $81.6 billion, an 85 percent year-on-year surge that beat the analyst consensus of $78.9 billion, and announced a massive share buyback authorization and a higher dividend.

The global equity backdrop has been supportive. The MSCI World index hit a record high, and global equity funds drew a net $39 billion in the week through 13 May — the largest weekly inflow since late April. Around 72 percent of MSCI World companies outperformed first-quarter earnings expectations. URTH itself attracted net inflows of $1.86 billion over the trailing twelve months and $3 billion cumulatively over three years, suggesting the fee question has not yet spooked the bulk of investors.

Nonetheless, the calendar ahead is packed with events that could test the fund’s appeal. The MSCI quarterly index review, announced on 12 May, takes effect at the close of trading on 29 May. Three new names join the index: Medline A, MasTec, and TechnipFMC — a modest tilt toward medical technology, infrastructure, and energy services. That rebalancing is followed by a free-float adjustment on 1 June, then an ex-dividend date on 15 June with a planned payout of $1.26 per share.

Shortly after, the Federal Reserve will hold its first meeting under new chair Kevin Warsh, who succeeded Jerome Powell. Warsh has signaled openness to lower interest rates while insisting on independence from political pressure. A rate cut would likely benefit the fund’s heavy tech exposure, but a hawkish surprise could trigger a sharp revaluation.

Looking further ahead, a potential SpaceX initial public offering in the second half of 2026 — valued at around $1.75 trillion with an offering volume of more than $75 billion — could significantly alter the composition of MSCI indices. Because MSCI weights members by free-float market capitalisation, an eventual inclusion would add weight to the already dominant US technology and aerospace segments. The US currently makes up 71.91 percent of URTH’s portfolio, and that weight was only slightly reduced in the latest adjustment after years of increases.

The fund’s trailing P/E ratio sits at 25, the price-to-book ratio near 4, and the dividend yield at 1.53 percent. Those valuations leave little room for disappointment, especially given the 19-basis-point handicap versus the cheapest peers. Morningstar’s gold medal validates the fund’s structure and track record, but in a market where 31 ETFs track the same index, low cost remains the most direct route to outperformance.